Polygenic risk scores in imaging genetics: Usefulness and applications

Journal of Psychopharmacology

Volumn 29, Issue 8, 2015, Pages 867-871

  Dima, Danai ^a,b   Breen, Gerome ^a,c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Bipolar disorder; Imaging genetics; Polygenic risk score; Psychiatry; Schizophrenia

Indexed keywords

ARTICLE; BIPOLAR DISORDER; CACNA1C GENE; CLINICAL PRACTICE; CORTICAL THICKNESS (BRAIN); DIAGNOSTIC VALUE; GENE; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC IMAGING; GENETIC RISK; HUMAN; IMAGING AND DISPLAY; PERSONALIZED MEDICINE; PHENOTYPIC VARIATION; POLYGENIC RISK SCORE; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK ASSESSMENT; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; MULTIFACTORIAL INHERITANCE; NEUROIMAGING;

BIPOLAR DISORDER; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MULTIFACTORIAL INHERITANCE; NEUROIMAGING; SCHIZOPHRENIA;

EID: 84937850524     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881115584470     Document Type: Article

References (66)

1. Alsabban S, Rivera M, McGuffin P, (2013) Genome-wide searches for bipolar disorder genes. Curr Psychiatry Rep 13: 522-527.
2. Aly M, Wiklund F, Xu J,. (2011) Polygenic risk score improves prostate cancer risk prediction: Results from the Stockholm-1 Cohort Study. Eur Urol 60: 21-28.
3. Athanasiu L, Mattingsdal M, Kahler AK,. (2010) Gene variants associated with schizophrenia in a Norwegian genome-wide study are replicated in a large European cohort. J Psychiatr Res 44: 748-753.
4. Chatterjee N, Wheeler B, Sampson J,. (2013) Projecting the performance of risk prediction based on polygenic analyses of genome-wide association studies. Nat Genet 45: 400-405.
5. Chen DT, Jiang X, Akula N,. (2013) Genome-wide association study meta-analysis of European and Asian-ancestry samples identifies three novel loci associated with bipolar disorder. Mol Psychiatry 18: 195-205.
6. Cichon S, Mühleisen TW, Degenhardt FA,. (2011) Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorder. Am J Hum Genet 88: 372-381.
7. Craddock N, Sklar P, (2009) Genetics of bipolar disorder: Successful start to a long journey. Trends Genet 25: 99-105.
8. Cross-Disorder Group of the Psychiatric Genomics Consortium; Genetic Risk Outcome of Psychosis (GROUP) Consortium (2013) Identification of risk loci with shared effects on five major psychiatric disorders: A genome-wide analysis. Lancet 381: 1371-1379.
9. Demirkan A, Penninx BW, Hek K,. (2011) Genetic risk profiles for depression and anxiety in adult and elderly cohorts. Mol Psychiatry 16: 773-783.
10. Derks EM, Vorstman JAS, Ripke S,. (2012) Investigation of the genetic association between quantitative Measures of psychosis and schizophrenia: A polygenic risk score analysis. PLoS One 7: e37852.
11. Dima D, Jogia J, Collier D,. (2013) Independent modulation of engagement and connectivity of the facial network during affect processing by CACNA1C and ANK3 risk genes for bipolar disorder. JAMA Psychiatry 70: 1303-1311.
12. Dudbridge F, (2013) Power and predictive accuracy of polygenic risk scores. PLoS Genet 9: e1003348.
13. Erk S, Meyer-Lindenberg A, Schmierer P,. (2013) Hippocampal and frontolimbic function as intermediate phenotype for psychosis: Evidence from healthy relatives and a common risk variant in CACNA1C. Biol Psychiatry 76: 466-475.
14. Ferreira MA, O'Donovan MC, Meng YA,. (2008) Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet 40: 1056-1058.
15. Franke B, Vasquez AA, Veltman JA,. (2010) Genetic variation in CACNA1C, a gene associated with bipolar disorder, influences brainstem rather than gray matter volume in healthy individuals. Biol Psychiatry 68: 586-588.
16. Friston KJ, Harrison L, Penny W, (2003) Dynamic causal modeling. NeuroImage 19: 1273-1302.
17. Fritsche LG, Chen W, Schu M,. (2013) Seven new loci associated with age-related macular degeneration. Nat Genet 45: 433-439.
18. Green EK, Grozeva D, Forty L,. (2013) Association at SYNE1 in both bipolar disorder and recurrent major depression. Mol Psychiatry 18: 614-617.
19. Hallden S, Sjogren M, Hedblad B,. (2013) Smoking and obesity associated BDNF gene variance predicts total and cardiovascular mortality in smokers. Heart 99: 949-953.
20. Hennekens CH, Hennekens AR, Hollar D,. (2005) Schizophrenia and increased risks of cardiovascular disease. Am Heart J 150: 1115-1121.
21. Holmes AJ, Lee PH, Hollinshead MO,. (2012) Individual differences in amygdala-medial prefrontal anatomy link negative affect, impaired social functioning, and polygenic depression risk. J Neurosci 32: 18087-18100.
22. Jogia J, Ruberto G, Lelli-Chiesa G,. (2011) The impact of the CACNA1C gene polymorphism on frontolimbic function in bipolar disorder. Mol Psychiatry 16: 1070-1071.
23. Kato M, Serretti A, (2010) Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder. Mol Psychiatry 15: 473-500.
24. Kempton MJ, Ruberto G, Vassos E,. (2009) Effects of the CACNA1C risk allele for bipolar disorder on cerebral gray matter volume in healthy individuals. Am J Psychiatry 166: 1413-1414.
25. Kim H, Lim SW, Kim S,. (2006) Monoamine transporter gene polymorphisms and antidepressant response in Koreans with late-life depression. JAMA 296: 1609-1618.
26. Kirchheiner J, Fuhr U, Brockmoller J, (2005) Pharmacogenetics-based therapeutic recommendations-ready for clinical practice? Nat Rev Drug Discov 4: 639-647.
27. Klein RJ, Zeiss C, Chew EY,. (2005) Complement factor H polymorphism in age-related macular degeneration. Science 308: 385-389.
28. Lander ES, Linton LM, Birren B,. (2001) Initial sequencing and analysis of the human genome. Nature 409: 860-921.
29. Landrigan CP, Parry GJ, Bones CB,. (2010) Temporal trends in rates of patient harm resulting from medical care. N Engl J Med 363: 2124-2134.
30. Lazarou J, Pomeranz BH, Corey PN, (1998) Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies. JAMA 279: 1200-1205.
31. Lichtenstein P, Yip BH, Bjork C,. (2009) Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: A population-based study. Lancet 373: 234-239.
32. Luciano M, Huffman JE, Arias-Vásquez A,. (2012) Genome-wide association uncovers shared genetic effects among personality traits and mood states. Am J Med Genet B Neuropsychiatr Genet 159: 684-695.
33. McGuffin P, Rijsdijk F, Andrew M,. (2003) The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Arch Gen Psychiatry 60: 497-502.
34. Middeldorp CM, de Moor MH, McGrath LM,. (2011) The genetic association between personality and major depression or bipolar disorder. A polygenic score analysis using genome-wide association data. Transl Psychiatry 1: e50.
35. Mrazek DA, Lerman C, (2011) Facilitating clinical implementation of pharmacogenomics. JAMA 306: 304-305.
36. O'Donovan MC, Craddock N, Norton N,. (2008) Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet 40: 1053-1055.
37. Paulus FM, Bedenbender J, Krach S,. (2014) Association of rs1006737 in CACNA1C with alterations in prefrontal activation and fronto-hippocampal connectivity. Hum Brain Mapp 35: 1190-1200.
38. Perrier E, Pompei F, Ruberto G,. (2011) Initial evidence for the role of CACNA1C on subcortical brain morphology in patients with bipolar disorder. Eur Psychiatry 26: 135-137.
39. Peterson RE, Maes HH, Holmans P,. (2011) Genetic risk sum score comprised of common polygenic variation is associated with body mass index. Hum Genet 129: 221-230.
40. Phillips DP, Barker GE, (2010) A July spike in fatal medication errors: A possible effect of new medical residents. J Gen Intern Med 25: 774-779.
41. Purcell SM, Wray NR, Stone JL,. (2009) Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460: 748-752.
42. Radua J, Surguladze SA, Marshall N,. (2013) The impact of CACNA1C allelic variation on effective connectivity during emotional processing in bipolar disorder. Mol Psychiatry 18: 526-527.
43. Rasetti R, Weinberger DR, (2011) Intermediate phenotypes in psychiatric disorders. Curr Opin Genet Dev 21: 340-348.
44. Rasetti R, Sambataro F, Chen Q,. (2011) Altered cortical network dynamics: A potential intermediate phenotype for schizophrenia and association with ZNF804A. Arch Gen Psychiatry 68: 1207-1217.
45. Ripke S, Neale B, Corvin A,. (2014) Biological insights from 108 schizophrenia-associated genetic loci. Nature 511: 421-427.
46. Ripke S, O'Dushlaine C, Chambert K,. (2013) Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nature Genet 45: 1150-1159.
47. Ripke S, Sanders AR, Kendler KS,. (2011) Genome-wide association study identifies five new schizophrenia loci. Nat Genet 43: 969-976.
48. Schulze TG, Detera-Wadleigh SD, Akula N,. (2009) Two variants in Ankyrin 3 (ANK3) are independent genetic risk factors for bipolar disorder. Mol Psychiatry 14: 487-491.
49. Scott LJ, Muglia P, Kong XQ,. (2009) Genome-wide association and meta-analysis of bipolar disorder in individuals of European ancestry. Proc Natl Acad Sci U S A 106: 7501-7506.
50. Shi J, Levinson DF, Duan J,. (2009) Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 460: 753-757.
51. Sklar P, Ripke S, Scott LJ,. (2011) Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet 43: 977-983.
52. Sklar P, Smoller JW, Fan J,. (2008) Whole-genome association study of bipolar disorder. Mol Psychiatry 13: 558-569.
53. Smith EN, Bloss CS, Badner JA,. (2009) Genome-wide association study of bipolar disorder in European American and African American individuals. Mol Psychiatry 14: 755-763.
54. Speliotes EK, Willer CJ, Berndt SI,. (2010) Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet 42: 937-948.
55. Stefansson H, Ophoff RA, Steinberg S,. (2009) Common variants conferring risk of schizophrenia. Nature 460: 744-747.
56. Sullivan PF, Kendler KS, Neale MC, (2003) Schizophrenia as a complex trait: Evidence from a meta-analysis of twin studies. Arch Gen Psychiatry 60: 1187-1192.
57. Tan HY, Chen AG, Kolachana B,. (2012) Effective connectivity of AKT1-mediated dopaminergic working memory networks and pharmacogenetics of anti-dopaminergic treatment. Brain 135: 1436-1445.
58. Tansey KE, Guipponi M, Perroud N,. (2012) Genetic predictors of response to serotonergic and noradrenergic antidepressants in major depressive disorder: A genome-wide analysis of individual-level data and a meta-analysis. PLoS Med 9: e1001326.
59. Tesli M, Koefoed P, Athanasiu L,. (2011) Association analysis of ANK3 gene variants in Nordic bipolar disorder and schizophrenia case-control samples. Am J Med Genet B Neuropsychiatr Genet 156B: 969-974.
60. Tesli M, Skatun KC, Ousdal OT,. (2013) CACNA1C risk variant and amygdala activity in bipolar disorder, schizophrenia and healthy controls. PLoS One 8: e56970.
61. van Scheltinga AFT, Bakker SC, van Haren NEM,. (2013) Schizophrenia genetic variants are not associated with intelligence. Psychol Med 43: 2563-2570.
62. Vorstman JAS, Anney RJL, Derks EM,. (2013) No evidence that common genetic risk variation is shared between schizophrenia and autism. Am J Med Genet B Neuropsychiatr Genet 162: 55-60.
63. Walton E, Turner J, Gollub RL,. (2013) Cumulative genetic risk and prefrontal activity in patients with schizophrenia. Schizophr Bull 39: 703-711.
64. Wang F, McIntosh AM, He Y,. (2011) The association of genetic variation in CACNA1C with structure and function of a frontotemporal system. Bipolar Disord 13: 696-700.
65. Whalley HC, Papmeyer M, Sprooten E,. (2012) The influence of polygenic risk for bipolar disorder on neural activation assessed using fMRI. Transl Psychiatry 2: e130.
66. Whalley HC, Sprooten E, Hackett S,. (2013) Polygenic risk and white matter integrity in individuals at high risk of mood disorder. Biol Psychiatry 74: 280-286.